Evidence mapPaperPMID 39416783Full record

ReviewFrontiers in immunology2024

Role of complement factor D in cardiovascular and metabolic diseases.

Yingjin Kong, Naixin Wang, Zhonghua Tong, Dongni Wang, Penghe Wang, Qiannan Yang, Xiangyu Yan, Weijun Song, Zexi Jin, Maomao Zhang

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Plasma proteomics link menopause timing to brain aging and dementia risk.medRxiv : the preprint server for health sciences · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yingjin Kong *Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Naixin Wang *Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhonghua TongDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Dongni WangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Penghe WangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Qiannan YangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiangyu YanDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Weijun SongDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Zexi JinDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Maomao ZhangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the genesis and progression of cardiovascular and metabolic diseases (CVMDs), adipose tissue plays a pivotal and dual role. Complement factor D (CFD, also known as adipsin), which is mainly produced by adipocytes, is the rate-limiting enzyme of the alternative pathway. Abnormalities in CFD generation or function lead to aberrant immune responses and energy metabolism. A large number of studies have revealed that CFD is associated with CVMDs. Herein, we will review the current studies on the function and mechanism of CFD in CVMDs such as hypertension, coronary heart disease, ischemia/reperfusion injury, heart failure, arrhythmia, aortic aneurysm, obesity, insulin resistance, and diabetic cardiomyopathy.

Indexed as

Cardiovascular DiseasesComplement Factor DMetabolic DiseasesAdipose TissueAnimalsHumansComplement Factor Dadipsincardiovascular diseaseCFDinflammationmetabolic diseases

Identifiers

PMID39416783
PMCPMC11479899

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.